Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential vanilloid 1 (TRPV1) is a nonselective cation channel primarily expressed in nociceptive sensory neurons, functioning as a molecular integrator for diverse noxious stimuli like heat, acidic pH, and chemical ligands such as capsaicin. Its activation leads to pain sensations and modulates both acute and chronic pain states. Dysregulation of TRPV1 is implicated in various conditions like chronic pain, IBS, hypertension, and asthma, making it a therapeutic target. Activation can also lead to long-term synaptic depression via calcium-dependent mechanisms.
TRPV1 antagonists inhibit the activity of the TRPV1 channel, reducing pain and inflammation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient Receptor Potential Vanilloid 1 (TRPV1).